Scientists discovered molybdenum trioxide nanoparticles oxidize sulfite sulfate in liver

Artificial enzyme imitates the natural mechanism of liver cells

10:39 AM, 1st July 2014
Johannes Gutenberg University research news
Mode of action of molybdenum oxide nanoparticles: (a) treatment of sulfite oxidase deficient liver cells; (b) mitochondria are directly targeted, nanoparticles accumulate in proximity to the membrane; (c) sulfite is oxidized to cellular innocuous sulfate.

MAINZ, GERMANY: Scientists at Johannes Gutenberg University Mainz (JGU) have discovered that molybdenum trioxide nanoparticles oxidize sulfite to sulfate in liver cells in analogy to the enzyme sulfite oxidase. The functionalized molybdenum trioxide nanoparticles can cross the cellular membrane and accumulate at the mitochondria, where they can recover the activity of sulfite oxidase.

Sulfite oxidase is a molybdenum containing enzyme located in the mitochondria of liver and kidney cells, which catalyzes the oxidation of sulfite to sulfate during the protein and lipid metabolism and therefore plays an important role in cellular detoxification processes. A lack of functional sulfite oxidase is a rare but fatal genetic disease causing neurological disorders, mental retardation, physical deformities as well as degradation of the brain, which finally leads to premature death. Various dietary or drug treatments for a sulfite oxidase deficiency have been tried with moderate success.

It was the fact that molybdenum oxide is incorporated in the enzymes active site that provided the inspiration for the approach now taken by the team of scientists working under the lead of Wolfgang Tremel, Professor, JGU as well as Dr Dennis Strand and Professor Susanne Strand of the Department of Internal Medicine of the Mainz University Medical Centre. The researchers hope that this study may lay the basis for a therapeutic application of molybdenum trioxide nanoparticles and therefore new possibilities to treat sulfite oxidase deficiency.

Lowered sulfite oxidase levels can cause health problems even for otherwise healthy persons. In addition, sulfites are used as preservatives in food, eg, in red wine, grape juice, or pickles in a jar. People having low levels of the sulfite oxidase react with symptoms like fatigue, asthma, drop in blood sugar, or headache.

With their study the Mainz scientists enter scientifically uncharted territory, because so far there are just a few studies of enzymatically active nanoparticles. “It is indeed astonishing, that simple inorganic nanoparticles can mimic an enzymatic activity,” said Ruben Ragg, first author of this study. In a previous work Professor Wolfgang Tremel and his team had shown that vanadium oxide nanowires contain an enzymatically induced antifouling activity that efficiently prevents ships from being infested by marine microorganisms. “It is a long-standing goal of chemistry to synthesize artificial enzymes that imitate the essential and general principles of natural enzymes,” added Tremel.

There is growing evidence that nanoparticles can act as enzyme mimics. Some nanomaterials were reported to exhibit enzyme-like activities, but the hallmark of enzyme chemistry would be to catalyze transformations in cells in the presence of other competing reactions. This is difficult to achieve, as it requires compatibility with other cellular reactions operating under similar conditions and rates. Therefore, artificial enzymes are not only useful for an understanding of the reaction mechanism of native enzymes but also for future applications as therapeutic agents. At the same time, the use of molybdenum nanoparticles would have several benefits.

“Molybdenum oxide particles are considerably cheaper and also more stable than genetically produced enzymes,” added Dr Filipe Natalio, cooperation partner from Martin Luther University of Halle-Wittenberg. Natalio is designing new materials that can mimic complex structures found in nature by bringing together a wide range expertise from material sciences to biology and chemistry. The next steps of the project will be to test if the enzyme activity of the nanoparticles can be retained in living organisms.

© Johannes Gutenberg-University News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Towards new quantum technology from defects in diamond

WASHINGTON DC, US: New research shows that a remarkable defect in synthetic diamond produced by chemical vapor deposition allows researchers to measur ...

Read more
Uralkali acquires 25 pc stake in port terminal in Brazil

MOSCOW, RUSSIA/ANTONINA, BRAZIL: Uralkali, world’s largest potash producer, has acquired 25 per cent in Equiplan Participacoes SA, which is the ...

Read more
Mitsui announces restructuring plan, closes few production facilities

TOKYO, JAPAN: Japanese chemical major Mitsui Chemicals Inc has announced a major restructuring plan, which involves closing down of some production fa ...

Read more
Diamond sheet may be obtained without pressure

HOUSTON, US: Perfect sheets of diamond a few atoms thick appear to be possible even without the big squeeze that makes natural gems. Scientists call t ...

Read more
New promising approach to targeted drug delivery

WASHINGTON DC, US: Many of today’s therapeutic drugs cause potential side effects. These effects often occur when a drug is active throughout th ...

Read more
Linde to supply hydrogen to Nynas’ refinery in Hamburg, Germany

MUNICH, GERMANY: The Linde Group has signed a long-term contract with Nynas AB, one of the world leaders in the naphthenic specialty oils (NSP) and th ...

Read more